Blaine Winters

Operations Director at NanoLayr

Blaine Ah Yuk-Winters is currently the Operations Director at NanoLayr. Prior to this, they served as the Interim Chief Operations Officer at NanoLayr from October 2019 to February 2021. Before that, they were an Investment Manager at Pan Pacific Capital, Ltd. from June 2015 to February 2021. From June 2015 to January 2018, they were an Analyst at GRC SinoGreen Fund III. And from June 2010 to May 2015, they were a Business Analyst and Project Manager at The OpShop and Lypanosys Pte Ltd, respectively.

Blaine has experience across all aspects of drug development and has managed key parts of this process, including managing overall budgets, timelines and reporting; successful filling of two key patent applications with the USPTO; preclinical and toxicology outsourcing, including the design and implementation of efficacy and ADME studies; CMC development, including compilation of the CMC package for submission to the US FDA; and clinical development, including the salvage of clinical data and study report from an under performing CRO for submission to the US FDA as well as the management of activities surrounding the implementation of the company's Phase 2b clinical trial.

Blaine Ah Yuk-Winters has a Bachelor of Science (BSc) from the University of Auckland in Biomedical Sciences, General. Blaine also has a MBioEnt from The University of Auckland in Masters of Bioscience Enterprise (First Class Honours).

Blaine Ah Yuk-Winters reports to Ray Connor, CEO. They work with Laura Knight - Head of Marketing, Graham Chester - Interim Financial Controller, and Dean Barker - Technical Director. Brendon Stevens - IT Support Manager, Alex Peddie - Production Manager, and Vacancy - HR Advisor report to Blaine Ah Yuk-Winters.

Links

Timeline

  • Operations Director

    Current role

View in org chart